Respiratory Tract Neoplasms  >>  docetaxel  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
docetaxel / Generic mfg.
NCT00536107: Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Terminated
4
14
RoW
Gefitinib, IRESSA, CT or MRI, Docetaxel, Paxel
AstraZeneca
Carcinoma, Non-Small-Cell Lung
08/09
08/09
NCT01442909: Pemetrexed Followed by Docetaxel or in Reverse Sequence

Completed
4
44
RoW
Docetaxel and pemetrexed, taxotere, alimta
Taipei Veterans General Hospital, Taiwan
Non-small-cell Lung Cancer
09/09
09/09
NCT00883675: Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Completed
4
133
US, RoW
Docetaxel-Carboplatin, Taxotere, Paraplatin
Michael Mann, Sanofi
Non-small Cell Lung Cancer
09/12
12/12

Download Options